Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Reinforces commitment to sustainable, quality ingredients.
June 26, 2020
By: Contract Pharma
Contract Pharma Staff
After scrupulous testing of raw material sourcing and manufacturing, DuPont Nutrition & Biosciences’ SeaGel CAP101 and SeaGel CAP203 non-animal soft capsule technologies have achieved Non-GMO Project Verified certification. SeaGel offers a plant-based alternative to traditional soft capsules, which are traditionally made with gelatin. Naturally derived from seaweed, SeaGel is animal-free, making it inclusive to vegan, vegetarian, Halal and Kosher diets. Its recent non-GMO designation allows manufacturers incorporating SeaGel into their formulation to appeal to a wider range of consumers. “As consumers become more informed about what goes into their daily supplements, they’re searching for products that are natural, sustainable and non-GMO,” said Michael Baumann, global strategic marketing manager, DuPont Nutrition & Biosciences. “Adding the iconic non-GMO butterfly to their end products helps manufacturers and brand owners provide customers with immediate assurance that a product aligns with their lifestyle needs.” SeaGel offers manufacturers solutions to a range of formulation challenges, and when compared to alternative vegetarian soft capsule technology, it provides superior sealing performance and reduced leakage. Since seaweed has a higher melting point than gelatin, SeaGel soft capsules are more heat stable, ensuring they will not become sticky or melt together inside capsule bottles. Its adaptability to shape, color and coating—plus easy incorporation into existing gelatin manufacturing operations—allows for a wide range of brand strategies with minimum capital investment, says the company. “The dietary supplement market is growing rapidly, with 4,000 new products introduced each year in the U.S. alone,” said Benjamin Roscoe, application development & innovation manager, DuPont Nutrition & Biosciences. “By consistently evolving alongside our customers, we’re empowering them to differentiate from competitors and meet consumer demand with safe, natural and sustainably sourced ingredients.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !